Terbinafine-induced subacute cutaneous lupus erythematosus
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hall, 1997, Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients, Arch Dermatol, 133, 1213, 10.1001/archderm.1997.03890460029004
Gupta, 1998, Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature, Br J Dermatol, 138, 529, 10.1046/j.1365-2133.1998.02140.x
Brooke, 1998, Terbinafine-induced subacute cutaneous lupus erythematosus, Br J Dermatol, 139, 1132, 10.1046/j.1365-2133.1998.2576q.x
Holmes, 1998, Exacerbation of systemic lupus erythematosus induced by terbinafine, Br J Dermatol, 139, 1133, 10.1046/j.1365-2133.1998.2576r.x
Murphy, 1998, Terbinafine-induced lupus erythematosus, Br J Dermatol, 138, 708, 10.1046/j.1365-2133.1998.02194.x
Faergemann, 1993, Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks, Acta Derm Venereol, 73, 305, 10.2340/000155557300304
Sontheimer, 1979, Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset, Arch Dermatol, 115, 1409, 10.1001/archderm.1979.04010120007006
Jensen, 1989, Clinical pharmacokinetics of terbinafine (Lamisil), Clin Exp Dermatol, 14, 110, 10.1111/j.1365-2230.1989.tb00904.x
Abdel-Rahman, 1999, Investigation of terbinafine as a CYP2D6 inhibitor in vivo, Clin Pharmacol Ther, 65, 465, 10.1016/S0009-9236(99)70065-2
Crowson, 1997, Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy, Hum Pathol, 28, 67, 10.1016/S0046-8177(97)90281-1
Provost, 1996, Significance of the anti-Ro(SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease, J Am Acad Dermatol, 35, 147, 10.1016/S0190-9622(96)90315-1
Goeteyn, 2000, Is systemic autoimmune disease a risk factor for terbinafine-induced erythema multiforme?, Br J Dermatol, 142, 578, 10.1046/j.1365-2133.2000.03391.x
Furukawa, 1999, Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity, Clin Exp Immunol, 118, 164, 10.1046/j.1365-2249.1999.01026.x
Adams, 1991, Drug-related lupus: incidence, mechanisms and clinical implications, Drug Saf, 6, 431, 10.2165/00002018-199106060-00004
Rubin, 1997, Drug-induced lupus, 871
Dunphy, 2000, Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome, Br J Dermatol, 142, 461, 10.1046/j.1365-2133.2000.03357.x
Reed, 1985, Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy, Ann Intern Med, 103, 49, 10.7326/0003-4819-103-1-49
Fernandez-Diaz, 1995, Subacute cutaneous lupus erythematosus associated with cilazapril, Lancet, 345, 398, 10.1016/S0140-6736(95)90392-5
Toll, 1998, Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy, Lupus, 7, 364, 10.1191/096120398678920244
Parodi, 1989, Subacute cutaneous lupus erythematosus-like eruption caused by hydrochlorothiazide, Photodermatology, 6, 100
Wollenberg, 1991, Thiazid-Diuretika-induzierter subakut-kutaner Lupus erythematodes, Hautarzt, 42, 709
Nousari, 1998, Subacute cutaneous lupus erythematosus associated with interferon beta- 1a, Lancet, 352, 1825, 10.1016/S0140-6736(05)79887-1
Crowson, 1999, Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy, J Cutan Pathol, 26, 95, 10.1111/j.1600-0560.1999.tb01809.x
Brenner, 1978, Cinnarizin: ein bisher unbekannter Induktor eines Lupus-erythematodes-ähnlichen Syndroms, Hautarzt, 29, 392
Patri, 1985, Lupus erythematosus-like eruption from captopril, Acta Derm Venereol, 65, 447, 10.2340/0001555565447448
Miyagawa, 1989, Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin, J Am Acad Dermatol, 21, 343, 10.1016/S0190-9622(89)80031-3
